previously reported drug price increases Valeant comes to mind Valeant Drug Company's Price Strategy Immoral featured in a prominent story in the New York Times noted one patient, after profiting for years Drug Company's Price Strategy Immoral According to the Times after profiting for years According to the Times featured in a prominent story in the New York Times Drug Company's Price Strategy Immoral Drug Company's Price Strategy Immoral Drug Company's Price Strategy Immoral after profiting for years New York Times profiled raised the prices of its brand-name drugs by 66% after profiting for years after profiting for years Drug Company's Price Strategy Immoral Drug Company's Price Strategy Immoral Valeant an astonishing nine times after profiting for years after profiting for years buying up old drugs Drug Company's Price Strategy Immoral after profiting for years snippet of the NYT article raising the prices after profiting for years Drug Company's Price Strategy Immoral Drug Company's Price Strategy Immoral after profiting for years raised the prices of its brand-name drugs by 66% raised the prices of its brand-name drugs by 66% Drug Company's Price Strategy Immoral Drug Company's Price Strategy Immoral Drug Company's Price Strategy Immoral Drug Company's Price Strategy Immoral NYTimes Drug Company's Price Strategy Immoral buying rights to older drugs Pharm-bitrage after profiting for years The New York Times Drug Company's Price Strategy Immoral Drug Company's Price Strategy Immoral Drug Company's Price Strategy Immoral Drug Company's Price Strategy Immoral Drug Company's Price Strategy Immoral described capitalized raised the prices of its brand-name drugs by 66%